Finding Treatments for Genetic Metabolic Disease
Current Pediatrics Reports, ISSN: 2167-4841, Vol: 4, Issue: 4, Page: 173-177
2016
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Review Description
Genetic metabolic diseases are comprised of a vast array of single-gene disorders that affect critical cellular biochemical pathways. Various approaches have been taken to treating individual metabolic diseases, each aimed at mitigating specific biochemical pathway deficiencies through targeting facets of cellular function. These approaches include targeting at the gene, enzyme, and biochemical levels via methodologies such as direct gene modification, enzyme replacement therapy, substrate reduction therapy, cofactor administration, dietary management, and organ transplantation. In this review, an overview of each of these approaches will be provided, and representative therapies in each category will be discussed.
Bibliographic Details
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know